Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05786430
What this trial is testing

Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib

Who this might be right for
Non-small Cell Lung Cancer
Yonsei University 87
Large-scale testing (Phase 3)Looking for participantsNCT07155187
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie 490
Testing effectiveness (Phase 2)Study completedNCT01362296
What this trial is testing

An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 134
Not applicableActive Not RecruitingNCT07024862
What this trial is testing

Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Bristol-Myers Squibb 100
Large-scale testing (Phase 3)UnknownNCT03668496
What this trial is testing

SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC

Who this might be right for
Lung Cancer Squamous CellLung Cancer Stage IVPD-1 Antibody+1 more
Jiangsu HengRui Medicine Co., Ltd. 390
Testing effectiveness (Phase 2)Ended earlyNCT00955305
What this trial is testing

Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Large Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)Study completedNCT00454194
What this trial is testing

Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 110
Not applicableUnknownNCT02934360
What this trial is testing

TR(ACE) Assay Clinical Specimen Study

Who this might be right for
Carcinoma, Non-Small-Cell LungBreast Neoplasms
Biological Dynamics 450
Post-approval studies (Phase 4)Study completedNCT01230710
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 51
Testing effectiveness (Phase 2)Study completedNCT00798603
What this trial is testing

Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 65
Testing effectiveness (Phase 2)Study completedNCT00673569
What this trial is testing

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Early research (Phase 1)UnknownNCT03976856
What this trial is testing

Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Genor Biopharma Co., Ltd. 42
Large-scale testing (Phase 3)Study completedNCT00556322
What this trial is testing

Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 424
Testing effectiveness (Phase 2)Active Not RecruitingNCT03620669
What this trial is testing

1st Line Durvalumab in PS 2 NSCLC Patients

Who this might be right for
NSCLC Stage IVNSCLC Stage IIIB
Swiss Cancer Institute 48
Testing effectiveness (Phase 2)Study completedNCT00723957
What this trial is testing

Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer
R-Pharm 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT04743505
What this trial is testing

Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Washington University School of Medicine 27
Large-scale testing (Phase 3)Study completedNCT01999673
What this trial is testing

Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer Stage IIIBNon-Small-Cell Lung Cancer Stage IVNon-Small-Cell Lung Cancer Metastatic+4 more
Peregrine Pharmaceuticals 582
Large-scale testing (Phase 3)Study completedNCT02367794
What this trial is testing

Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]

Who this might be right for
Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,021
Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Testing effectiveness (Phase 2)Ended earlyNCT04639245
What this trial is testing

Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 1
Next Page